Article
Survival analysis in breast cancer using proteomic data from four independent datasets
2020-12-04
Abstract excerpt
<h4>ABSTRACT</h4> Breast cancer clinical treatment selection is based on the immunohistochemical determination of four proteins: ESR1, PGR, HER2, and MKI67. Our aim was to correlate immunohistochemical results to proteome-level technologies in measuring the expression of these markers. We also aimed to integrate available proteome-level breast cancer datasets to identify and validate new prognostic biomarker candi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b7f5da5c-a95a-5709-a851-823d3b956fc6
- DOI
- 10.1101/2020.12.03.20242065
